These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Skeletal complications and the use of bisphosphonates in metastatic prostate cancer.
    Author: Drudge-Coates L.
    Journal: Int J Palliat Nurs; 2006 Oct; 12(10):462-9. PubMed ID: 17167378.
    Abstract:
    Metastatic prostate cancer represents an incurable progression of the disease that accounts for the vast majority of disease related mortality and is associated with significant skeletal morbidity with events including bone pain, fractures and spinal cord compression. This article provides an overview of the bone disease in this patient group, with a specific focus on the role of bisphosphonate use, in addressing quality of life issues. Key clinical trial data relating to bisphosphonates is presented and discussed, culminating in key management guidelines.
    [Abstract] [Full Text] [Related] [New Search]